Publication | Closed Access
41 Preliminary results of a randomized comparative phase III trial of topotecan (T) versus CAV as second-line therapy of small cell lung cancer (SCLC)
11
Citations
0
References
1997
Year
Cancer TherapeuticsMedicineMetronomic TherapyPreliminary ResultsBronchial NeoplasmCancer TreatmentSecond-line TherapyOncologyRadiation OncologyLung CancerVersus CavRadiologyHealth Sciences
No additional data available for this publication yet. Check back later!